These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36754008)

  • 1. Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
    Oberdhan D; Cole JC; Atkinson MJ; Krasa HB; Davison SN; Perrone RD
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):213-222. PubMed ID: 36754008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
    Hoover E; Holliday V; Merullo N; Oberdhan D; Perrone RD; Rusconi C; Park M; Phadnis MA; Thewarapperuma N; Dahl NK
    Kidney Med; 2024 May; 6(5):100813. PubMed ID: 38689835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
    Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
    Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
    Natale P; Hannan E; Sautenet B; Ju A; Perrone RD; Burnette E; Casteleijn N; Chapman A; Eastty S; Gansevoort R; Hogan M; Horie S; Knebelmann B; Lee R; Mustafa RA; Sandford R; Baumgart A; Tong A; Strippoli GFM; Craig JC; Rangan GK; Cho Y
    PLoS One; 2021; 16(5):e0252479. PubMed ID: 34043715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
    Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
    Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease.
    Oberdhan D; Yarlas A; Bjorner JB; Krasa H
    Kidney Med; 2024 Jan; 6(1):100755. PubMed ID: 38192435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic Kidney Disease-Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative Study.
    Oberdhan D; Schaefer F; Cole JC; Palsgrove AC; Dandurand A; Guay-Woodford L
    Kidney Med; 2022 Mar; 4(3):100415. PubMed ID: 35386599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
    Sautenet B; Cho Y; Gutman T; Rangan G; Ong A; Chapman AB; Ahn C; Coolican H; Tze-Wah Kao J; Fowler K; Gansevoort RT; Geneste C; Perrone RD; Harris T; Torres VE; Pei Y; Craig JC; Tong A;
    Am J Kidney Dis; 2020 Aug; 76(2):213-223. PubMed ID: 32171640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.
    Joly D; Quinn J; Mokiou S; O'Reilly K; Sánchez-Covisa J; Wang-Silvanto J; Doll H
    BMC Nephrol; 2020 Jul; 21(1):298. PubMed ID: 32709218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
    Cho Y; Tong A; Craig JC; Mustafa RA; Chapman A; Perrone RD; Ahn C; Fowler K; Torres V; Gansevoort RT; Ong ACM; Coolican H; Tze-Wah Kao J; Harris T; Gutman T; Shen JI; Viecelli AK; Johnson DW; Au E; El-Damanawi R; Logeman C; Ju A; Manera KE; Chonchol M; Odland D; Baron D; Pei Y; Sautenet B; Rastogi A; Sharma A; Rangan G;
    Am J Kidney Dis; 2021 Feb; 77(2):255-263. PubMed ID: 32771648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
    Rizk D; Jurkovitz C; Veledar E; Bagby S; Baumgarten DA; Rahbari-Oskoui F; Steinman T; Chapman AB
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):560-6. PubMed ID: 19261830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses.
    Raymond K; Maher S; Saucier CD; O'Connor M; Yarlas A; Kosinski M; Chen WH; Gairy K
    Rheumatol Ther; 2023 Feb; 10(1):95-115. PubMed ID: 36227531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD.
    Hoover E; Perrone RD; Rusconi C; Benson B; Dahl NK; Gitomer B; Manelli A; Mrug M; Park M; Seliger SL; Phadnis MA; Thewarapperuma N; Watnick TJ
    Kidney360; 2022 Aug; 3(8):1350-1358. PubMed ID: 36176661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease.
    Wong ATY; Munt A; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Chandra AN; Coulshed S; Fernando M; Grantham J; Haloob I; Harris DCH; Hawley CM; Holt J; Johnson DW; Kumar K; Lee VW; Lonergan M; Mai J; Rangan A; Roger SD; Saravanabavan S; Sud K; Torres VE; Vilayur E; Zhang JQJ; Rangan GK
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33147804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease.
    El-Damanawi R; Lee M; Harris T; Cowley LB; Scholtes I; Bond S; Sandford RN; Wilkinson IB; Casteleijn NF; Hogan MC; Karet Frankl FE; Hiemstra TF
    Clin Kidney J; 2021 Nov; 14(11):2338-2348. PubMed ID: 34754429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.